<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/). Abstract Atopic" exact="dermatitis" post="(AD) is a chronic recurrent skin disease dominated by"/>
 <result pre="can become a promising new therapy strategy for AD. momelotinib" exact="atopic dermatitis" post="cytokine DNCB dendritic cell JAK/STAT pathway 1. Introduction Atopic"/>
 <result pre="become a promising new therapy strategy for AD. momelotinib atopic" exact="dermatitis" post="cytokine DNCB dendritic cell JAK/STAT pathway 1. Introduction Atopic"/>
 <result pre="dermatitis cytokine DNCB dendritic cell JAK/STAT pathway 1. Introduction Atopic" exact="dermatitis" post="(AD) is a chronic recurrent skin disease characterized by"/>
 <result pre="signaling pathway may be participated in the stimulation of DNCB-induced" exact="atopic dermatitis" post="mice. Moreover, the effectiveness of MMB on AD mice"/>
 <result pre="pathway may be participated in the stimulation of DNCB-induced atopic" exact="dermatitis" post="mice. Moreover, the effectiveness of MMB on AD mice"/>
 <result pre="to declare. References References 1. Weidinger S. Novak N. Atopic" exact="dermatitis" post="Lancet 2016 387 1109 1122 10.1016/S0140-6736(15)00149-X 26377142 2. Bieber"/>
 <result pre="E. et al. Consensus conference on clinical management of pediatric" exact="atopic dermatitis" post="Ital. J. Pediatr. 2016 42 1 25 10.1186/s13052-016-0229-8 26743447"/>
 <result pre="et al. Consensus conference on clinical management of pediatric atopic" exact="dermatitis" post="Ital. J. Pediatr. 2016 42 1 25 10.1186/s13052-016-0229-8 26743447"/>
 <result pre="topical corticosteroids and topical calcineurin inhibitors for the treatment of" exact="atopic dermatitis" post="in thin and sensitive skin areas Curr. Med. Res."/>
 <result pre="corticosteroids and topical calcineurin inhibitors for the treatment of atopic" exact="dermatitis" post="in thin and sensitive skin areas Curr. Med. Res."/>
 <result pre="effects of topical tacrolimus and steroids in daily management of" exact="atopic dermatitis" post="J. Dermatol. 2004 31 277 283 10.1111/j.1346-8138.2004.tb00673.x 15187322 6."/>
 <result pre="of topical tacrolimus and steroids in daily management of atopic" exact="dermatitis" post="J. Dermatol. 2004 31 277 283 10.1111/j.1346-8138.2004.tb00673.x 15187322 6."/>
 <result pre="M. Pérezplaza A. Solanolópez G. Sánchezpérez J. Biological treatments in" exact="atopic dermatitis" post="J. Clin. Med. 2015 4 593 613 10.3390/jcm4040593 26239349"/>
 <result pre="Pérezplaza A. Solanolópez G. Sánchezpérez J. Biological treatments in atopic" exact="dermatitis" post="J. Clin. Med. 2015 4 593 613 10.3390/jcm4040593 26239349"/>
 <result pre="of the JAK-STAT signaling pathway in chronic inflammatory skin disease" exact="atopic dermatitis" post="JAK-STAT 2013 2 e24137 10.4161/jkst.24137 24069552 9. Schwartz D.M."/>
 <result pre="the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic" exact="dermatitis" post="JAK-STAT 2013 2 e24137 10.4161/jkst.24137 24069552 9. Schwartz D.M."/>
 <result pre="and preclinical studies using cell lines and primary cells from" exact="polycythemia" post="vera patients Leukemia 2009 23 1441 1445 10.1038/leu.2009.50 19295546"/>
 <result pre="J.F. Nagai H. Inhibition of scratching behavior associated with allergic" exact="dermatitis" post="in mice by tacrolimus, but not by dexamethasone Eur."/>
 <result pre="Mrowietz U. Rostami-Yazdi M. Oxidative stress in the pathogenesis of" exact="psoriasis" post="Free Radic. Biol. Med. 2009 47 891 905 10.1016/j.freeradbiomed.2009.06.033"/>
 <result pre="1619 10.1542/peds.2008-2139EEEE 17881745 25. Nomura T. Kabashima K. Advances in" exact="atopic dermatitis" post="in 2015 J. Allergy. Clin. Immunol. 2016 138 1548"/>
 <result pre="10.1542/peds.2008-2139EEEE 17881745 25. Nomura T. Kabashima K. Advances in atopic" exact="dermatitis" post="in 2015 J. Allergy. Clin. Immunol. 2016 138 1548"/>
 <result pre="keratinocytes through the JAK1, 2/Stat6 signal transduction pathway: Implication for" exact="atopic dermatitis" post="Mol. Immunol. 2012 50 91 97 10.1016/j.molimm.2011.12.008 22226123 28."/>
 <result pre="through the JAK1, 2/Stat6 signal transduction pathway: Implication for atopic" exact="dermatitis" post="Mol. Immunol. 2012 50 91 97 10.1016/j.molimm.2011.12.008 22226123 28."/>
 <result pre="reactivation, of TH2 effector responses in a mouse model of" exact="asthma" post="J. Allergy Clin. Immunol. 2004 114 166 173 10.1016/j.jaci.2004.03.044"/>
 <result pre="0.01, *** p &amp;lt; 0.001. Figure 7 Schematic diagram of" exact="atopic dermatitis" post="(AD) model establishment and treatment. ijms-19-03973-t001_Table 1 Table 1"/>
 <result pre="*** p &amp;lt; 0.001. Figure 7 Schematic diagram of atopic" exact="dermatitis" post="(AD) model establishment and treatment. ijms-19-03973-t001_Table 1 Table 1"/>
</results>
